| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |